In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Medtech Needs Clinical Registries for Pre- and Postmarket Data
Vicki Anastasi share her insights onclinical registries and generating pre- and postmarket datain this interiew in Medical Design and Outsourcing.
-
Precision Medicine and Data Science
In this article Peter Schueler outlines the future ofdrug development and the central role that precision medicinewill play in global healthcare.
-
Real-world Evidence and the ‘Unsticking’ of Health Care Data
Ramita Tandon outlines in this article in Managed Care how Pharma and CROs must set high standards for acceptablereal-world evidenceresearch.
-
The Future of Clinical Trials
In this article Jennifer Byrne discusses thefuture of clinical trials.
-
Preparing for 2026
Vicki Anastasi contributes to this article which looks atvalue-based healthcare, enabled by wearable and electronic health record (EHR) technologies.
-
2016 FDA Guidance Documents You Should Know
Gordon MacFarlane, senior manager of regulatory affairs and Cynthia Nolte, director of regulatory affairs outline the key points, benefits, and challenges of theFDA guidance documents during 2016 for medical device manufacturers.
-
One Answer to Your Postmarket Challenge: Planning
Interview with Vicki Anastasi onpostmarket surveillance and the challenges trial designs are facing.
-
The Clinical Trial of the Future
Steve Cutler talks to Pharma Times regarding industry trends inclinical trials and patient engagement.
-
Match This
Due to considerable market growth, biosimilar clinical trials are rising in popularity. One key example relates to rituximab, and the development of its biosimilars is currently leading the way in clinical research.
-
Remote Monitoring of Patients in Clinical Trials
Recent initiatives to redesign theclinical trial processhave in part focused on the creation of trials that are more patient focused.
